generic drugs

This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif.
Ben Margot/AP Photo, File
AP News
June 29, 2020 - 12:55 pm
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.
Read More